Absent expansion of AXIN2+ hepatocytes and altered physiology in Axin2CreERT2 mice challenges the role of pericentral hepatocytes in homeostatic liver regeneration.


Journal

Journal of hepatology
ISSN: 1600-0641
Titre abrégé: J Hepatol
Pays: Netherlands
ID NLM: 8503886

Informations de publication

Date de publication:
05 2023
Historique:
received: 07 10 2022
revised: 19 12 2022
accepted: 11 01 2023
medline: 18 4 2023
pubmed: 27 1 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

Mouse models of lineage tracing have helped to describe the important subpopulations of hepatocytes responsible for liver regeneration. However, conflicting results have been obtained from different models. Herein, we aimed to reconcile these conflicting reports by repeating a key lineage-tracing study from pericentral hepatocytes and characterising this Axin2CreERT2 model in detail. We performed detailed characterisation of the labelled population in the Axin2CreERT2 model. We lineage traced this cell population, quantifying the labelled population over 1 year and performed in-depth phenotypic comparisons, including transcriptomics, metabolomics and analysis of proteins through immunohistochemistry, of Axin2CreERT2 mice to WT counterparts. We found that after careful definition of a baseline population, there are marked differences in labelling between male and female mice. Upon induced lineage tracing there was no expansion of the labelled hepatocyte population in Axin2CreERT2 mice. We found substantial evidence of disrupted homeostasis in Axin2CreERT2 mice. Offspring are born with sub-Mendelian ratios and adult mice have perturbations of hepatic Wnt/β-catenin signalling and related metabolomic disturbance. We find no evidence of predominant expansion of the pericentral hepatocyte population during liver homeostatic regeneration. Our data highlight the importance of detailed preclinical model characterisation and the pitfalls which may occur when comparing across sexes and backgrounds of mice and the effects of genetic insertion into native loci. Understanding the source of cells which regenerate the liver is crucial to harness their potential to regrow injured livers. Herein, we show that cells which were previously thought to repopulate the liver play only a limited role in physiological regeneration. Our data helps to reconcile differing conclusions drawn from results from a number of prior studies and highlights methodological challenges which are relevant to preclinical models more generally.

Sections du résumé

BACKGROUND & AIMS
Mouse models of lineage tracing have helped to describe the important subpopulations of hepatocytes responsible for liver regeneration. However, conflicting results have been obtained from different models. Herein, we aimed to reconcile these conflicting reports by repeating a key lineage-tracing study from pericentral hepatocytes and characterising this Axin2CreERT2 model in detail.
METHODS
We performed detailed characterisation of the labelled population in the Axin2CreERT2 model. We lineage traced this cell population, quantifying the labelled population over 1 year and performed in-depth phenotypic comparisons, including transcriptomics, metabolomics and analysis of proteins through immunohistochemistry, of Axin2CreERT2 mice to WT counterparts.
RESULTS
We found that after careful definition of a baseline population, there are marked differences in labelling between male and female mice. Upon induced lineage tracing there was no expansion of the labelled hepatocyte population in Axin2CreERT2 mice. We found substantial evidence of disrupted homeostasis in Axin2CreERT2 mice. Offspring are born with sub-Mendelian ratios and adult mice have perturbations of hepatic Wnt/β-catenin signalling and related metabolomic disturbance.
CONCLUSIONS
We find no evidence of predominant expansion of the pericentral hepatocyte population during liver homeostatic regeneration. Our data highlight the importance of detailed preclinical model characterisation and the pitfalls which may occur when comparing across sexes and backgrounds of mice and the effects of genetic insertion into native loci.
IMPACT AND IMPLICATIONS
Understanding the source of cells which regenerate the liver is crucial to harness their potential to regrow injured livers. Herein, we show that cells which were previously thought to repopulate the liver play only a limited role in physiological regeneration. Our data helps to reconcile differing conclusions drawn from results from a number of prior studies and highlights methodological challenges which are relevant to preclinical models more generally.

Identifiants

pubmed: 36702176
pii: S0168-8278(23)00021-1
doi: 10.1016/j.jhep.2023.01.009
pii:
doi:

Substances chimiques

AXIN2 protein, human 0
Axin Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1028-1036

Subventions

Organisme : Cancer Research UK
ID : 26813
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A17196
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A31287
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A29252
Pays : United Kingdom
Organisme : Wellcome Trust
ID : WT107492Z
Pays : United Kingdom
Organisme : Cancer Research UK
ID : A25045
Pays : United Kingdom

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier B.V. All rights reserved.

Auteurs

Stephanie May (S)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Miryam Müller (M)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Callum R Livingstone (CR)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

George L Skalka (GL)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Peter J Walsh (PJ)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK.

Colin Nixon (C)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Ann Hedley (A)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Robin Shaw (R)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

William Clark (W)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Johan Vande Voorde (J)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Leah Officer-Jones (L)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Fiona Ballantyne (F)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Ian R Powley (IR)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Thomas M Drake (TM)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK; Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK.

Christos Kiourtis (C)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK.

Andrew Keith (A)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Ana Sofia Rocha (AS)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

Saverio Tardito (S)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK.

David Sumpton (D)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK.

John Le Quesne (J)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK; Department of Histopathology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, UK.

Martin Bushell (M)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK.

Owen J Sansom (OJ)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK.

Thomas G Bird (TG)

Cancer Research UK Beatson Institute, Glasgow, G61 1BD, UK; School of Cancer Sciences, University of Glasgow, Garscube Estate, Switchback Road, Glasgow, G61 1QH, UK; MRC Centre for Inflammation Research, The Queen's Medical Research Institute, University of Edinburgh, EH164TJ, UK. Electronic address: t.bird@beatson.gla.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH